These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38762080)

  • 1. Satisfaction with government recommended pre-procedural mouth rinses in the mitigation of Covid-19 in Hong Kong SAR: A triple blind randomized controlled clinical trial.
    Huang S; Leung YY; Neelakantan P; Chan KH; Leung JKY; Hung FN; McGrath C
    J Dent; 2024 Jul; 146():105082. PubMed ID: 38762080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore.
    Seneviratne CJ; Balan P; Ko KKK; Udawatte NS; Lai D; Ng DHL; Venkatachalam I; Lim KS; Ling ML; Oon L; Goh BT; Sim XYJ
    Infection; 2021 Apr; 49(2):305-311. PubMed ID: 33315181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial.
    Elzein R; Abdel-Sater F; Fakhreddine S; Hanna PA; Feghali R; Hamad H; Ayoub F
    J Evid Based Dent Pract; 2021 Sep; 21(3):101584. PubMed ID: 34479668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaque inhibition of two commercially available chlorhexidine mouthrinses.
    Van Strydonck DA; Timmerman MF; van der Velden U; van der Weijden GA
    J Clin Periodontol; 2005 Mar; 32(3):305-9. PubMed ID: 15766375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of mouthrinses in reducing oral SARS-COV-2 load: a review.
    Pannuti CM; Reis INRD; Souza NV; Souto MLS; Silva CGB; Bezinelli LM; Machado CM; Romito GA; Villar CC
    Braz Oral Res; 2023; 37():e038. PubMed ID: 37132726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouth rinses efficacy on salivary SARS-CoV-2 viral load: A randomized clinical trial.
    Alzahrani MM; Bamashmous S; Alkharobi H; Alghamdi A; Alharbi RH; Hassan AM; Darwish M; Bukhari A; Mahmoud AB; Alfaleh MA; Mirza AA; Abuzenadah AM; Abujamel TS; Hashem AM
    J Med Virol; 2023 Jan; 95(1):e28412. PubMed ID: 36527332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
    Khan FR; Kazmi SMR; Iqbal NT; Iqbal J; Ali ST; Abbas SA
    Trials; 2020 Sep; 21(1):785. PubMed ID: 32928313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The short-term effect of different chlorhexidine forms versus povidone iodine mouth rinse in minimizing the oral SARS-CoV-2 viral load: An open label randomized controlled clinical trial study.
    Natto ZS; Bakhrebah MA; Afeef M; Al-Harbi S; Nassar MS; Alhetheel AF; Ashi H
    Medicine (Baltimore); 2022 Jul; 101(30):e28925. PubMed ID: 35905275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of antiseptic mouthrinses against SARS-CoV-2: A prospective randomized placebo-controlled pilot study.
    Fantozzi PJ; Pampena E; Pierangeli A; Oliveto G; Sorrentino L; Di Vanna D; Pampena R; Lazzaro A; Gentilini E; Mastroianni CM; D'Ettorre G; Polimeni A; Romeo U; Villa A
    Am J Otolaryngol; 2022; 43(6):103549. PubMed ID: 35988522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of 3 mouthrinses on plaque and gingivitis development.
    Maruniak J; Clark WB; Walker CB; Magnusson I; Marks RG; Taylor M; Clouser B
    J Clin Periodontol; 1992 Jan; 19(1):19-23. PubMed ID: 1310096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A short-term clinical study design to investigate the chemical plaque inhibitory properties of mouthrinses when used as adjuncts to toothpastes: applied to chlorhexidine.
    Owens J; Addy M; Faulkner J; Lockwood C; Adair R
    J Clin Periodontol; 1997 Oct; 24(10):732-7. PubMed ID: 9350557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of polyvinyl pyrrolidone on the clinical activity of 0.09% and 0.2% chlorhexidine mouthrinses.
    Claydon N; Manning CM; Darby-Dowman A; Ridge D; Smith S; Addy M
    J Clin Periodontol; 2001 Nov; 28(11):1037-44. PubMed ID: 11686825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 6-month clinical study assessing the safety and efficacy of two cetylpyridinium chloride mouthrinses.
    Stookey GK; Beiswanger B; Mau M; Isaacs RL; Witt JJ; Gibb R
    Am J Dent; 2005 Jul; 18 Spec No():24A-28A. PubMed ID: 16178133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of two new chlorhexidine mouthrinses on the development of dental plaque, gingivitis, and discolouration. A randomized, investigator-blind, placebo-controlled, 3-week experimental gingivitis study.
    Lorenz K; Bruhn G; Heumann C; Netuschil L; Brecx M; Hoffmann T
    J Clin Periodontol; 2006 Aug; 33(8):561-7. PubMed ID: 16899099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do antibacterial mouthrinses affect bacteraemia in third molar surgery? A pilot study.
    Tuna A; Delilbasi C; Arslan A; Gurol Y; Tazegun Tekkanat Z
    Aust Dent J; 2012 Dec; 57(4):435-9. PubMed ID: 23186567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some effects of mouthrinses containing salifluor on de novo plaque formation and developing gingivitis.
    Furuichi Y; Ramberg P; Lindhe J; Nabi N; Gaffar A
    J Clin Periodontol; 1996 Aug; 23(8):795-802. PubMed ID: 8877668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is mouthrinsing before dental procedures worthwhile?
    Molinari JA; Molinari GE
    J Am Dent Assoc; 1992 Mar; 123(3):75-80. PubMed ID: 1545061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 2 commercially available chlorhexidine mouthrinses.
    Keijser JA; Verkade H; Timmerman MF; Van der Weijden FA
    J Periodontol; 2003 Feb; 74(2):214-8. PubMed ID: 12666710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of mouth rinses with povidone-iodine and hydrogen peroxide in patients with COVID-19.
    Pablo-Marcos D; Abascal B; Lloret L; Gutiérrez Cuadra M; Velasco N; Valero C
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Mar; 41(3):173-175. PubMed ID: 36058840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compare the effcacy of two commercially available mouthrinses in reducing viable bacterial count in dental aerosol produced during ultrasonic scaling when used as a preprocedural rinse.
    Shetty SK; Sharath K; Shenoy S; Sreekumar C; Shetty RN; Biju T
    J Contemp Dent Pract; 2013 Sep; 14(5):848-51. PubMed ID: 24685786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.